MOMETASONE MEDIS mometasone furoate 0.1% w/w ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

mometasone medis mometasone furoate 0.1% w/w ointment tube

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; white soft paraffin; white beeswax; propylene glycol monostearate - mometasone medis ointment is indicated for short-term (up to 4 continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis.

MOMETASONE MEDIS mometasone furoate 0.1% w/w cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

mometasone medis mometasone furoate 0.1% w/w cream tube

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - cream - excipient ingredients: stearyl alcohol; propylene glycol monostearate; aluminium starch octenylsuccinate; titanium dioxide; ceteareth-20; white soft paraffin; propylene glycol; purified water; phosphoric acid; white beeswax - mometasone medis cream is indicated for short-term (up to 4 continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis.

NASONEX- mometasone furoate spray, metered United States - English - NLM (National Library of Medicine)

nasonex- mometasone furoate spray, metered

physicians total care, inc. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 50 ug - nasonex® nasal spray 50 mcg is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis, in adults and pediatric patients 2 years of age and older. nasonex nasal spray 50 mcg is indicated for the relief of nasal congestion associated with seasonal allergic rhinitis, in adults and pediatric patients 2 years of age and older. nasonex nasal spray 50 mcg is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older. nasonex nasal spray 50 mcg is indicated for the treatment of nasal polyps in patients 18 years of age and older. nasonex nasal spray is contraindicated in patients with known hypersensitivity to mometasone furoate or any of its ingredients. teratogenic effects: pregnancy category c: there are no adequate and well-controlled studies in pregnant women. nasonex nasal spray 50 mcg, like other corticosteroids, should be used during pregnancy only if the potential benefits justify the p

ASMANEX- mometasone furoate inhalant United States - English - NLM (National Library of Medicine)

asmanex- mometasone furoate inhalant

merck sharp & dohme corp. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 220 ug - asmanex® twisthaler® is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 4 years of age and older. limitations of use asmanex twisthaler is not indicated for the relief of acute bronchospasm. asmanex twisthaler is not indicated in children less than 4 years of age. asmanex twisthaler is contraindicated: - status asthmaticus: in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. - hypersensitivity: in patients with known hypersensitivity to milk proteins or any ingredients of asmanex twisthaler [see warnings and precautions (5.3) and description (11)]. risk summary there are no adequate and well-controlled studies of asmanex twisthaler in pregnant women. there are clinical considerations with the use of asmanex twisthaler in pregnant women [see clinical considerations] . in animal reproduction studies with pregnant mice, rats, or rabbits, mometasone furoate caused increased fetal malfo

UNICLAR AQUEOUS NASAL SPRAY 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol Australia - English - Department of Health (Therapeutic Goods Administration)

uniclar aqueous nasal spray 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol

organon pharma pty ltd - mometasone furoate, quantity: 50 microgram/actuation - spray, suspension - excipient ingredients: benzalkonium chloride; citric acid monohydrate; sodium citrate dihydrate; dispersible cellulose; glycerol; citric acid; polysorbate 80; purified water - uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis in adults, adolescents and children between the ages of 3 and 11 years. uniclar aqueous nasal spray 0.05% is also indicated for the treatment of nasal polyps in adult patients 18 years of age and older. uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of severe bacterial infection.

ZATAMIL 0.1% OINTMENT mometasone furoate 0.1% w/w (1 mg/g) ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% ointment mometasone furoate 0.1% w/w (1 mg/g) ointment tube

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; citric acid; light liquid paraffin; purified water; white soft paraffin; polyethylene; colloidal anhydrous silica; cetostearyl alcohol - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.

ZATAMIL 0.1% HYDROGEL mometasone furoate 0.1% w/w (1 mg/g) gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% hydrogel mometasone furoate 0.1% w/w (1 mg/g) gel tube

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - gel - excipient ingredients: hexylene glycol; citric acid; hypromellose; purified water - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.

ZATAMIL 0.1% LOTION mometasone furoate 0.1% w/w (1 mg/g) lotion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% lotion mometasone furoate 0.1% w/w (1 mg/g) lotion bottle

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: industrial methylated spirit; citric acid; propylene glycol; hypromellose; purified water - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.,zatamil lotion is suitable for use in scalp psoriaris and application to other areas of the body.

MOMASONE mometasone furoate 1mg/g ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

momasone mometasone furoate 1mg/g ointment tube

aspen pharma pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; hexylene glycol; white beeswax; purified water; propylene glycol monostearate; phosphoric acid - indicated for short-term (up to four continuous weeks) relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis & atopic dermatitis.

MOMASONE mometasone furoate 0.1% w/w lotion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

momasone mometasone furoate 0.1% w/w lotion bottle

medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: monobasic sodium phosphate; phosphoric acid; propylene glycol; hyprolose; isopropyl alcohol; purified water - short-term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis. the lotion is also suitable for short-term use for scalp psoriasis and seborrhoeic dermatitis.